Back to today’s briefing

Story perspectives

Dual-cell scaffold improves aniridia keratopathy vision in trial

8/29/2026

48 5 Full Breakdown

Summary

Story summary

UK researchers at Moorfields Eye Hospital and UCL implanted a dual scaffold for aniridia keratopathy.
Three months after implantation, ocular surface scores fell from 9.4 to 5.9.
At twelve months, treated eyes scored 6.7 versus 8.0 in untreated eyes.
Vision improved by an average of 24 ETDRS letters, about five chart lines.
Professor Sajjad Ahmad called it the first dual-cell scaffold and said a trial will target NHS adoption.

1 of 1

Story summary

UK researchers at Moorfields Eye Hospital and UCL implanted a dual scaffold for aniridia keratopathy.
Three months after implantation, ocular surface scores fell from 9.4 to 5.9.
At twelve months, treated eyes scored 6.7 versus 8.0 in untreated eyes.
Vision improved by an average of 24 ETDRS letters, about five chart lines.
Professor Sajjad Ahmad called it the first dual-cell scaffold and said a trial will target NHS adoption.